In addition, PHF19 can promote proliferation in hepatocellular carcinoma, glioma, and ovarian cancers (Xu et al., 2015; Lu et al., 2018; Tao et al., 2018) and can induce glioblastoma progression, mediated by β-catenin (Deng et al., 2018). Here, PHF19 is linked to glioblastoma.